- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Coeptis Therapeutics Holdings Inc (COEP)
Coeptis Therapeutics Holdings Inc stock price live, this page displays NASDAQ COEP stock exchange data. View the COEP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Coeptis Therapeutics Holdings Inc real time stock price chart below.
What Is the Coeptis Therapeutics Holdings Inc Stock Price Today?
The Coeptis Therapeutics Holdings Inc stock price today is 11.160.
What Is the Stock Symbol for Coeptis Therapeutics Holdings Inc?
The stock symbol for Coeptis Therapeutics Holdings Inc is ""COEP.""
What Stock Exchange Does Coeptis Therapeutics Holdings Inc Trade On?
Coeptis Therapeutics Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Coeptis Therapeutics Holdings Inc a Good Stock to Buy?
Determining whether Coeptis Therapeutics Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the COEP quote. (ISIN: US19207A2078)
What Is the Coeptis Therapeutics Holdings Inc Stock Price Today?
The Coeptis Therapeutics Holdings Inc stock price today is 11.160.
What Is the Stock Symbol for Coeptis Therapeutics Holdings Inc?
The stock symbol for Coeptis Therapeutics Holdings Inc is ""COEP.""
What Stock Exchange Does Coeptis Therapeutics Holdings Inc Trade On?
Coeptis Therapeutics Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Coeptis Therapeutics Holdings Inc a Good Stock to Buy?
Determining whether Coeptis Therapeutics Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the COEP quote. (ISIN: US19207A2078)
NASDAQ
Currency in USD
11.160
+0.560(+5.28%)
Closed·
After Hours
11.220+0.060(+0.54%)
·
Fair Value
An estimate of a Coeptis Therapeutics Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.710
11.160
52 wk Range
2.310
13.700
COEP Scorecard
Full Analysis
Stock price often moves in the opposite direction of the market
COEP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Coeptis Therapeutics Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.71011.160
52 wk Range
2.31013.700
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
COEP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Coeptis Therapeutics Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Coeptis Therapeutics Holdings Inc Company Profile
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio and rights are licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, natural killer cell therapy technology. Its product pipeline consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy; and SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological and solid tumors. In addition, the company offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson’s Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.
Compare COEP to Peers and Sector
Metrics to compare | COEP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCOEPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.0x | −1.7x | −0.5x | |
PEG Ratio | −0.07 | 0.01 | 0.00 | |
Price/Book | 6.1x | 2.3x | 2.6x | |
Price / LTM Sales | 623.7x | 6.7x | 3.3x | |
Upside (Analyst Target) | - | 120.5% | 43.5% | |
Fair Value Upside | Unlock | 15.0% | 6.8% | Unlock |
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-1.00 / --
Revenue / Forecast
62.87K / --
People Also Watch
FAQ
What Stock Exchange Does Coeptis Therapeutics Holdings Trade On?
Coeptis Therapeutics Holdings is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Coeptis Therapeutics Holdings?
The stock symbol for Coeptis Therapeutics Holdings is "COEP."
What Is the Coeptis Therapeutics Holdings Market Cap?
As of today, Coeptis Therapeutics Holdings market cap is 39.21M.
What Is Coeptis Therapeutics Holdings's Earnings Per Share (TTM)?
The Coeptis Therapeutics Holdings EPS (TTM) is -4.39.
From a Technical Analysis Perspective, Is COEP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Coeptis Therapeutics Holdings Stock Split?
Coeptis Therapeutics Holdings has split 1 times.
How Many Employees Does Coeptis Therapeutics Holdings Have?
Coeptis Therapeutics Holdings has 6 employees.
What is the current trading status of Coeptis Therapeutics Holdings (COEP)?
As of 09 Aug 2025, Coeptis Therapeutics Holdings (COEP) is trading at a price of 11.16, with a previous close of 10.60. The stock has fluctuated within a day range of 10.71 to 11.16, while its 52-week range spans from 2.31 to 13.70.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.